Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Zika Virus Vaccines Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Research Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Zika Virus Vaccines Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 DNA Vaccine
      • 1.3.3 Inactivated Vaccine
      • 1.3.4 Purified Inactivated Vaccine
      • 1.3.5 Table of Contents
    • 1.4 Market Segment by Application
      • 1.4.1 Global Zika Virus Vaccines Market Share by Application (2019-2025)
      • 1.4.2 Hospitals
      • 1.4.3 Clinics
      • 1.4.4 Academic and Research
      • 1.4.5 Others
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Production and Capacity Analysis
      • 2.1.1 Global Zika Virus Vaccines Production Value 2014-2025
      • 2.1.2 Global Zika Virus Vaccines Production 2014-2025
      • 2.1.3 Global Zika Virus Vaccines Capacity 2014-2025
      • 2.1.4 Global Zika Virus Vaccines Marketing Pricing and Trends
    • 2.2 Key Producers Growth Rate (CAGR) 2019-2025
      • 2.2.1 Global Zika Virus Vaccines Market Size CAGR of Key Regions
      • 2.2.2 Global Zika Virus Vaccines Market Share of Key Regions
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Capacity and Production by Manufacturers
      • 3.1.1 Global Zika Virus Vaccines Capacity by Manufacturers
      • 3.1.2 Global Zika Virus Vaccines Production by Manufacturers
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Zika Virus Vaccines Revenue by Manufacturers (2014-2019)
      • 3.2.2 Zika Virus Vaccines Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Zika Virus Vaccines Market Concentration Ratio (CR5 and HHI)
    • 3.3 Zika Virus Vaccines Price by Manufacturers
    • 3.4 Key Manufacturers Zika Virus Vaccines Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Zika Virus Vaccines Market
    • 3.6 Key Manufacturers Zika Virus Vaccines Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Production and Production Value for Each Type
      • 4.1.1 DNA Vaccine Production and Production Value (2014-2019)
      • 4.1.2 Inactivated Vaccine Production and Production Value (2014-2019)
      • 4.1.3 Purified Inactivated Vaccine Production and Production Value (2014-2019)
      • 4.1.4 Table of Contents Production and Production Value (2014-2019)
    • 4.2 Global Zika Virus Vaccines Production Market Share by Type
    • 4.3 Global Zika Virus Vaccines Production Value Market Share by Type
    • 4.4 Zika Virus Vaccines Ex-factory Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Zika Virus Vaccines Consumption by Application

    6 Production by Regions

    • 6.1 Global Zika Virus Vaccines Production (History Data) by Regions 2014-2019
    • 6.2 Global Zika Virus Vaccines Production Value (History Data) by Regions
    • 6.3 United States
      • 6.3.1 United States Zika Virus Vaccines Production Growth Rate 2014-2019
      • 6.3.2 United States Zika Virus Vaccines Production Value Growth Rate 2014-2019
      • 6.3.3 Key Players in United States
      • 6.3.4 United States Zika Virus Vaccines Import & Export
    • 6.4 European Union
      • 6.4.1 European Union Zika Virus Vaccines Production Growth Rate 2014-2019
      • 6.4.2 European Union Zika Virus Vaccines Production Value Growth Rate 2014-2019
      • 6.4.3 Key Players in European Union
      • 6.4.4 European Union Zika Virus Vaccines Import & Export
    • 6.5 China
      • 6.5.1 China Zika Virus Vaccines Production Growth Rate 2014-2019
      • 6.5.2 China Zika Virus Vaccines Production Value Growth Rate 2014-2019
      • 6.5.3 Key Players in China
      • 6.5.4 China Zika Virus Vaccines Import & Export
    • 6.6 Rest of World
      • 6.6.1 Japan
      • 6.6.2 Korea
      • 6.6.3 India
      • 6.6.4 Southeast Asia

    7 Zika Virus Vaccines Consumption by Regions

    • 7.1 Global Zika Virus Vaccines Consumption (History Data) by Regions
    • 7.2 United States
      • 7.2.1 United States Zika Virus Vaccines Consumption by Type
      • 7.2.2 United States Zika Virus Vaccines Consumption by Application
    • 7.3 European Union
      • 7.3.1 European Union Zika Virus Vaccines Consumption by Type
      • 7.3.2 European Union Zika Virus Vaccines Consumption by Application
    • 7.4 China
      • 7.4.1 China Zika Virus Vaccines Consumption by Type
      • 7.4.2 China Zika Virus Vaccines Consumption by Application
    • 7.5 Rest of World
      • 7.5.1 Rest of World Zika Virus Vaccines Consumption by Type
      • 7.5.2 Rest of World Zika Virus Vaccines Consumption by Application
      • 7.5.1 Japan
      • 7.5.2 Korea
      • 7.5.3 India
      • 7.5.4 Southeast Asia

    8 Company Profiles

    • 8.1 NHI
      • 8.1.1 NHI Company Details
      • 8.1.2 Company Description and Business Overview
      • 8.1.3 Production and Revenue of Zika Virus Vaccines
      • 8.1.4 Zika Virus Vaccines Product Introduction
      • 8.1.5 NHI Recent Development
    • 8.2 Sanofi
      • 8.2.1 Sanofi Company Details
      • 8.2.2 Company Description and Business Overview
      • 8.2.3 Production and Revenue of Zika Virus Vaccines
      • 8.2.4 Zika Virus Vaccines Product Introduction
      • 8.2.5 Sanofi Recent Development
    • 8.3 GSK
      • 8.3.1 GSK Company Details
      • 8.3.2 Company Description and Business Overview
      • 8.3.3 Production and Revenue of Zika Virus Vaccines
      • 8.3.4 Zika Virus Vaccines Product Introduction
      • 8.3.5 GSK Recent Development
    • 8.4 Bharat.
      • 8.4.1 Bharat. Company Details
      • 8.4.2 Company Description and Business Overview
      • 8.4.3 Production and Revenue of Zika Virus Vaccines
      • 8.4.4 Zika Virus Vaccines Product Introduction
      • 8.4.5 Bharat. Recent Development
    • 8.5 Takeda
      • 8.5.1 Takeda Company Details
      • 8.5.2 Company Description and Business Overview
      • 8.5.3 Production and Revenue of Zika Virus Vaccines
      • 8.5.4 Zika Virus Vaccines Product Introduction
      • 8.5.5 Takeda Recent Development
    • 8.6 Inovio Pharmaceuticals
      • 8.6.1 Inovio Pharmaceuticals Company Details
      • 8.6.2 Company Description and Business Overview
      • 8.6.3 Production and Revenue of Zika Virus Vaccines
      • 8.6.4 Zika Virus Vaccines Product Introduction
      • 8.6.5 Inovio Pharmaceuticals Recent Development
    • 8.7 GeneOne Life Science Inc
      • 8.7.1 GeneOne Life Science Inc Company Details
      • 8.7.2 Company Description and Business Overview
      • 8.7.3 Production and Revenue of Zika Virus Vaccines
      • 8.7.4 Zika Virus Vaccines Product Introduction
      • 8.7.5 GeneOne Life Science Inc Recent Development
    • 8.8 PaxVax
      • 8.8.1 PaxVax Company Details
      • 8.8.2 Company Description and Business Overview
      • 8.8.3 Production and Revenue of Zika Virus Vaccines
      • 8.8.4 Zika Virus Vaccines Product Introduction
      • 8.8.5 PaxVax Recent Development
    • 8.9 Gilead Sciences Inc.
      • 8.9.1 Gilead Sciences Inc. Company Details
      • 8.9.2 Company Description and Business Overview
      • 8.9.3 Production and Revenue of Zika Virus Vaccines
      • 8.9.4 Zika Virus Vaccines Product Introduction
      • 8.9.5 Gilead Sciences Inc. Recent Development
    • 8.10 Intrexon Corp.
      • 8.10.1 Intrexon Corp. Company Details
      • 8.10.2 Company Description and Business Overview
      • 8.10.3 Production and Revenue of Zika Virus Vaccines
      • 8.10.4 Zika Virus Vaccines Product Introduction
      • 8.10.5 Intrexon Corp. Recent Development
    • 8.11 NewLink Genetics Corp

    9 Market Forecast

    • 9.1 Global Market Size Forecast
      • 9.1.1 Global Zika Virus Vaccines Capacity, Production Forecast 2019-2025
      • 9.1.2 Global Zika Virus Vaccines Production Value Forecast 2019-2025
    • 9.2 Market Forecast by Regions
      • 9.2.1 Global Zika Virus Vaccines Production and Value Forecast by Regions 2019-2025
      • 9.2.2 Global Zika Virus Vaccines Consumption Forecast by Regions 2019-2025
    • 9.3 United States
      • 9.3.1 Production and Value Forecast in United States
      • 9.3.2 Consumption Forecast in United States
    • 9.4 European Union
      • 9.4.1 Production and Value Forecast in European Union
      • 9.4.2 Consumption Forecast in European Union
    • 9.5 China
      • 9.5.1 Production and Value Forecast in China
      • 9.5.2 Consumption Forecast in China
    • 9.6 Rest of World
      • 9.6.1 Japan
      • 9.6.2 Korea
      • 9.6.3 India
      • 9.6.4 Southeast Asia
    • 9.7 Forecast by Type
      • 9.7.1 Global Zika Virus Vaccines Production Forecast by Type
      • 9.7.2 Global Zika Virus Vaccines Production Value Forecast by Type
    • 9.8 Consumption Forecast by Application

    10 Value Chain and Sales Channels Analysis

    • 10.1 Value Chain Analysis
    • 10.2 Sales Channels Analysis
      • 10.2.1 Zika Virus Vaccines Sales Channels
      • 10.2.2 Zika Virus Vaccines Distributors
    • 10.3 Zika Virus Vaccines Customers

    11 Opportunities & Challenges, Threat and Affecting Factors

    • 11.1 Market Opportunities
    • 11.2 Market Challenges
    • 11.3 Porter's Five Forces Analysis

    12 Key Findings

      13 Appendix

      • 13.1 Research Methodology
        • 13.1.1 Methodology/Research Approach
          • 13.1.1.1 Research Programs/Design
          • 13.1.1.2 Market Size Estimation
          • 13.1.1.3 Market Breakdown and Data Triangulation
        • 13.1.2 Data Source
          • 13.1.2.1 Secondary Sources
          • 13.1.2.2 Primary Sources
      • 13.2 Author Details

      In 2019, the market size of Zika Virus Vaccines is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Zika Virus Vaccines.

      This report studies the global market size of Zika Virus Vaccines, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Zika Virus Vaccines production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      NHI
      Sanofi
      GSK
      Bharat.
      Takeda
      Inovio Pharmaceuticals
      GeneOne Life Science Inc
      PaxVax
      Gilead Sciences Inc.
      Intrexon Corp.
      NewLink Genetics Corp

      Market Segment by Product Type
      DNA Vaccine
      Inactivated Vaccine
      Purified Inactivated Vaccine
      Table of Contents

      Market Segment by Application
      Hospitals
      Clinics
      Academic and Research
      Others

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Zika Virus Vaccines status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Zika Virus Vaccines manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Zika Virus Vaccines are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now